全文获取类型
收费全文 | 576篇 |
免费 | 39篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 5篇 |
妇产科学 | 11篇 |
基础医学 | 110篇 |
口腔科学 | 1篇 |
临床医学 | 57篇 |
内科学 | 124篇 |
皮肤病学 | 26篇 |
神经病学 | 73篇 |
特种医学 | 7篇 |
外科学 | 42篇 |
综合类 | 2篇 |
预防医学 | 44篇 |
眼科学 | 2篇 |
药学 | 31篇 |
中国医学 | 1篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 3篇 |
2022年 | 6篇 |
2021年 | 22篇 |
2020年 | 15篇 |
2019年 | 15篇 |
2018年 | 14篇 |
2017年 | 16篇 |
2016年 | 22篇 |
2015年 | 23篇 |
2014年 | 25篇 |
2013年 | 32篇 |
2012年 | 38篇 |
2011年 | 36篇 |
2010年 | 19篇 |
2009年 | 27篇 |
2008年 | 37篇 |
2007年 | 41篇 |
2006年 | 26篇 |
2005年 | 29篇 |
2004年 | 27篇 |
2003年 | 36篇 |
2002年 | 38篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1998年 | 11篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1964年 | 1篇 |
排序方式: 共有616条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
Kapelko-Słowik K Wołowiec D Sedek K Jaźwiec B Urbaniak-Kujda D Kuliczkowski K 《Polskie Archiwum Medycyny Wewn?trznej》2002,108(3):849-853
Cyclin-dependent kinases (cdk) play the important role in neoplastic transformation. Their activity depends on interaction with proteins called inhibitors. There are two groups of inhibitors: INK4 (p16INK4a, p15INK4b, p18INK4c, p19INK4d) and proteins p21WAF1/Clip1, p27Kip1, p57Kip2. Alteration of inhibitors expression was assessed in acute lymphoblastic leukemia (ALL) and in acute myeloblastic leukemia (AML), but the results are not clear. The aim of our study was to estimate p16INK4a, p15INK-4b, p21WAF1/Clip1 expression in blast cells in patients with AML and ALL by cytochemistry method and to compare with the result of treatment. Forty-two patients were included in the study, 23 with AML and 19 with ALL. Expression of inhibitors was considered as positive when detected in > 5% of blast cells. Complete remission (CR) rate in patients with positive expression p16INK4a and p15INK4b was statistically significantly higher than in patients with negative expression: for p16INK4a chi 2 = 7.78, p < 0.01, for p15INK4b, chi 2 with Yates' modification = 3.94, p < 0.05. There was no difference in CR rate in patients with positive and negative p21WAF1/Clip1 expression. Moreover the patients with simultaneous expression of three inhibitors reached CR more often than the others: chi 2 = 7.43, p = 0.01 for AML and chi 2 = 6.74, p < 0.01 for ALL. Our study indicates that estimation of p16INK4a, p15INK4b, p21WAF1/Clip1 expression in blast cells can be used as prognostic factor in acute leukemia. 相似文献
45.
TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples 总被引:6,自引:0,他引:6
Lazarus R Raby BA Lange C Silverman EK Kwiatkowski DJ Vercelli D Klimecki WJ Martinez FD Weiss ST 《American journal of respiratory and critical care medicine》2004,170(6):594-600
TOLL-like receptor 10 (TLR10) is the most recently identified human homolog of the Drosophila TOLL protein. In humans, the TOLL-like receptors recognize pathogen-associated molecular patterns (PAMPs) as part of innate immune host defenses. Localized to chromosome 4p14, the specific ligands and functions of TLR10 are currently unknown, although it is expressed in lung and in B-lymphocytes. TLR10 is a potential asthma candidate gene because early life innate immune responses to ubiquitous inhaled allergens and PAMPs may influence asthma susceptibility. Resequencing in 47 subjects revealed a total of 78 single nucleotide polymorphisms (SNPS) (1 SNP per 106 bp) of which only 11 had been previously published. A significant association (p < or = 0.02) between two SNPs (c.+1031G>A, c.+2322A>G) and physician-diagnosed asthma was observed in a case control study (517 cases, 519 control subjects) of European American subjects nested within the Nurses' Health Study cohort. The association for these same two SNPs (p < or = 0.015) replicated in an independent family based cohort, where a measure of airway hyperresponsiveness (PC20) was also associated (p = 0.026 for c.+1031G>A). Consistent association in two independent samples and association with an intermediate phenotype provides strong support for TLR10 genetic variation contributing to asthma risk. 相似文献
46.
Maria Donata Spazzini MD Antonella Villa MD Cristina Maffioletti MD Federica Mariuzzo MD Giuseppe Calì MD 《Journal of clinical ultrasound : JCU》2020,48(5):298-300
Cesarean scar pregnancies are relatively rare. In the first trimester, if the decision is made to terminate the pregnancy, it should be done as soon as possible to avoid complications. We report a successful termination of a live, 6 weeks and 4 days cesarean scar pregnancy using a double-balloon cervical ripening catheter in a patient with two previous cesarean deliveries. 相似文献
47.
Basak GW Knopinska-Posluszny W Matuszak M Kisiel E Hawrylecka D Szmigielska-Kaplon A Urbaniak-Kujda D Dybko J Zielinska P Dabrowska-Iwanicka A Werkun J Rzepecki P Wroblewska W Wiktor-Jedrzejczak W 《Annals of hematology》2011,90(5):557-568
Recent developments in the field of targeted therapy have led to the discovery of a new drug, plerixafor, that is a specific inhibitor of the CXCR4 receptor. Plerixafor acts in concert with granulocyte colony-stimulating factor (G-CSF) to increase the number of stem cells circulating in the peripheral blood (PB). Therefore, it has been applied in the field of hematopoietic stem cell mobilization. We analyzed retrospectively data regarding stem cell mobilization with plerixafor in a cohort of 61 patients suffering from multiple myeloma (N?=?23), non-Hodgkin's lymphoma (N?=?20), or Hodgkin's lymphoma (N?=?18). At least one previous mobilization attempt had failed in 83.6% of these patients, whereas 16.4% were predicted to be poor mobilizers. The median number of CD34+ cells in the PB after the first administration of plerixafor was 22/μL (range of 0-121). In total, 85.2% of the patients proceeded to cell collection, and a median of two (range of 0-4) aphereses were performed. A minimum of 2.0?×?10(6) CD34+ cells per kilogram of the patient's body weight (cells/kg b.w.) was collected from 65.6% of patients, and the median number of cells collected was 2.67?×?10(6) CD34+ cells/kg b.w. (0-8.0). Of the patients, 55.7% had already undergone autologous stem cell transplantation, and the median time to neutrophil and platelet reconstitution was 12 and 14?days, respectively. Cases of late graft failure were not observed. We identified the diagnosis of non-Hodgkin's lymphoma and previous radiotherapy as independent factors that contributed to failure of mobilization. The current report demonstrates the satisfactory efficacy of plerixafor plus G-CSF for stem cell mobilization in heavily pre-treated poor or predicted poor mobilizers. 相似文献
48.
Vitagliano D De Falco V Tamburrino A Coluzzi S Troncone G Chiappetta G Ciardiello F Tortora G Fagin JA Ryan AJ Carlomagno F Santoro M 《Endocrine-related cancer》2011,18(1):1-11
Oncogenic conversion of the RET tyrosine kinase is a frequent feature of medullary thyroid carcinoma (MTC). ZD6474 (vandetanib) is an ATP-competitive inhibitor of RET, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptors kinases. In this study, we have studied ZD6474 mechanism of action in TT and MZ-CRC-1 human MTC cell lines, carrying cysteine 634 to tryptophan (C634W) and methionine 918 to threonine (M918T) RET mutation respectively. ZD6474 blunted MTC cell proliferation and RET, Shc and p44/p42 mitogen-activated protein kinase (MAPK) phosphorylation. Single receptor knockdown by RNA interference showed that MTC cells depended on RET for proliferation. Adoptive expression of the ZD6474-resistant V804M RET mutant rescued proliferation of TT cells under ZD6474 treatment, showing that RET is a key ZD6474 target in these MTC cells. Upon RET inhibition, adoptive stimulation of EGFR partially rescued TT cell proliferation, MAPK signaling, and expression of cell-cycle-related genes. This suggests that simultaneous inhibition of RET and EGFR by ZD6474 may overcome the risk of MTC cells to escape from RET blockade through compensatory over-activation of EGFR. 相似文献
49.
50.
Giuseppe Tagariello Rosanna Di Gaetano Roberto Sartori Daniela Zanotto Donata Belvini Paolo Radossi Renzo Risato Giovanni Roveroni Roberta Salviato Cristina Tassinari Nunzio Toffano 《Trasfusione del sangue》2009,7(2):111-116